Partnership Opportunities

Why Partner?

The 4th Chronic Kidney Disease Drug Development Summit (CKD3) is your opportunity to position your brand at the forefront of the minds of leading organizations prioritizing drug development in chronic and rare kidney diseases.

As the new era of predictive kidney organoids, robust animal models, early biomarkers of efficacy and innovative clinical trial design in clinically relevant subgroups transforms the opportunities to drive pipeline progression and expansion, ensure you are aligned with the elite experts guiding the next steps in kidney disease drug development.


How Can We Help You Win New Business?

We understand each business is different, so we will work with you to build a bespoke package to fulfil your business objectives and elevate your company’s influence by:

  • Placing your brand in front of a qualified audience
    Securing an exhibition booth to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies
  • Connecting you with the Right People
    Network one-to-one with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution
  • Sharing your high-quality content
    Deliver a presentation online and still be able to influence the thinking of translational and pre-clinical decision makers working to identify new promising compounds


Who Will You Meet?

Industry of attendees
Job titles of attendees

Get involved in this unique and exclusive platform to foster business relationships and position your organization as the thought leader and preferred long-term partner

Snapshot of Previous Attending Companies:

Daiichi Sankyo Co. Ltd.
Goldfinch Biopharma Inc.
Inception Sciences
Ionis Pharmaceuticals
Johnson & Johnson
Merck & Co
Reata Pharmaceuticals
Regeneron Pharmaceuticals
The Broad Institute of MIT & Harvard
Vertex Pharmaceuticals
Vifor Pharma

“Great opportunity where I made over 10 key contacts that would not have been made otherwise. Progressed one key collaboration already!"

ACEA Bioscience

"Good representation of pharma, biotech, CRO and regulatory colleagues, which lead to stimulating conversations and presentations on: pathophysiology, potential targets, challenges involved in clinical studies and developing regulatory and payer perspectives."


"Great event, exceptional networking opportunities. High quality of presentations. Very efficient way to spend my time "


"It's a 'small' forum where the business of science can be openly discussed. Intimate and focused "

Syneos Health